Using da Vinci SP System for Patients With Cholelithiasis and Choledocholithiasis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital

About this trial

A prospective, interventional, single arm study to investigate clinical feasibility of single-stage cholecystectomy and common bile duct exploration using da Vinci SP Surgical System (robotic surgery)

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 20 years or more

Symptomatic cholelithiasis with or without choledocholithiasis, symptomatic chronic cholecystitis with or without biliary tract injury or stricture

Indication of cholecystectomy with or without common bile duct exploration and deemed feasible for robotic surgery

Patient not feasible or have failed stone extraction or intervention for choledocholithiasis by endoscopic retrograde cholangiopancreatography for patients with choledocholithiasis could be included

Disqualifiers

Severe acute cholecystitis

Suspected biliary tract cancer or untreated biliary tract cancer

BMI ≥35 or BMI <18.5

Unable to tolerate robotic surgery position

Trial design

Design model

Single group

Treatments tested in this trial

  • da Vinci SP Surgery System

    Device

    da Vinci SP Surgery System

Treatment groups

25 Participants
are divided into 1 treatment group
Group A: Operation of focus procedure with da Vinci SP Surgery SystemExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of conversion rate

The primary performance endpoint will be assessed as the ability to successfully completed the planned procedure with da Vinci SP System, with no conversion to alternative surgery including open surgery or laparoscopy.

Time frame
During Surgery

Secondary outcomes

1

Incidence of Treatment Emergent Adverse Events

The safety endpoint will be assessed as the incidence of all intra-operatvie and post-operative adverse events that occur through the follow up period.

Time frame
up to 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.